Cargando…

Hepatobiliary dysfunction in Type-2 diabetes mellitus

OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) and gallstones are frequently present in diabetics, but its exact prevalence is not well studied in India. We have done a prevalence study of hepatobiliary involvement in Type-2 diabetes mellitus (T2DM) and also studied the other risk factors of NA...

Descripción completa

Detalles Bibliográficos
Autores principales: Manoria, Piyush, Inamdar, Sameer, Kumar, Ravindra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787956/
https://www.ncbi.nlm.nih.gov/pubmed/29417009
http://dx.doi.org/10.4103/2249-4863.222018
_version_ 1783296029220667392
author Manoria, Piyush
Inamdar, Sameer
Kumar, Ravindra
author_facet Manoria, Piyush
Inamdar, Sameer
Kumar, Ravindra
author_sort Manoria, Piyush
collection PubMed
description OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) and gallstones are frequently present in diabetics, but its exact prevalence is not well studied in India. We have done a prevalence study of hepatobiliary involvement in Type-2 diabetes mellitus (T2DM) and also studied the other risk factors of NAFLD. MATERIALS AND METHODS: Two hundred diabetics and 200 controls underwent anthropometric measurements, abdominal ultrasonography, (USG) and biochemical tests at a tertiary care hospital. Univariate and multivariate logistic regression analyses were done. RESULTS: One hundred and thirty (65%) diabetics and 47 (23.50%) controls were having USG evidence of fatty liver (odds ratio [OR] = 6.046, 95% confidence interval [CI]: 3.904–9.363 [P < 0.0001]). Raised liver enzymes were present in 42 (21%) diabetics and 16 (8%) controls [OR = 3.057, 95% CI: 1.654–5.648 [P < 0.004]). Gallstones were present in 32 (16%) diabetics and 10 (5%) controls (OR = 2.825; 95% CI: 1.850–4.315 P < 0.0001). In addition, waist circumference (WC) and body mass index (BMI) were significantly more in diabetics, but lipid profile was not significantly deranged as compared to controls. Then, all patients with fatty liver were compared with patients with normal liver, and we found that fatty liver group was having raised BMI, WC, liver enzymes, and more dyslipidemia. Multivariate analysis was done which shows the presence of T2DM, elevated liver enzymes, obesity, and elevated WC as independent risk factors of fatty liver. CONCLUSION: The prevalence of NAFLD and gallstones was higher in diabetics as compared to healthy population. In addition, the presence of T2DM, elevated liver enzymes, obesity, and elevated WC are independent predictors of NAFLD.
format Online
Article
Text
id pubmed-5787956
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-57879562018-02-07 Hepatobiliary dysfunction in Type-2 diabetes mellitus Manoria, Piyush Inamdar, Sameer Kumar, Ravindra J Family Med Prim Care Original Article OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) and gallstones are frequently present in diabetics, but its exact prevalence is not well studied in India. We have done a prevalence study of hepatobiliary involvement in Type-2 diabetes mellitus (T2DM) and also studied the other risk factors of NAFLD. MATERIALS AND METHODS: Two hundred diabetics and 200 controls underwent anthropometric measurements, abdominal ultrasonography, (USG) and biochemical tests at a tertiary care hospital. Univariate and multivariate logistic regression analyses were done. RESULTS: One hundred and thirty (65%) diabetics and 47 (23.50%) controls were having USG evidence of fatty liver (odds ratio [OR] = 6.046, 95% confidence interval [CI]: 3.904–9.363 [P < 0.0001]). Raised liver enzymes were present in 42 (21%) diabetics and 16 (8%) controls [OR = 3.057, 95% CI: 1.654–5.648 [P < 0.004]). Gallstones were present in 32 (16%) diabetics and 10 (5%) controls (OR = 2.825; 95% CI: 1.850–4.315 P < 0.0001). In addition, waist circumference (WC) and body mass index (BMI) were significantly more in diabetics, but lipid profile was not significantly deranged as compared to controls. Then, all patients with fatty liver were compared with patients with normal liver, and we found that fatty liver group was having raised BMI, WC, liver enzymes, and more dyslipidemia. Multivariate analysis was done which shows the presence of T2DM, elevated liver enzymes, obesity, and elevated WC as independent risk factors of fatty liver. CONCLUSION: The prevalence of NAFLD and gallstones was higher in diabetics as compared to healthy population. In addition, the presence of T2DM, elevated liver enzymes, obesity, and elevated WC are independent predictors of NAFLD. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5787956/ /pubmed/29417009 http://dx.doi.org/10.4103/2249-4863.222018 Text en Copyright: © 2017 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Manoria, Piyush
Inamdar, Sameer
Kumar, Ravindra
Hepatobiliary dysfunction in Type-2 diabetes mellitus
title Hepatobiliary dysfunction in Type-2 diabetes mellitus
title_full Hepatobiliary dysfunction in Type-2 diabetes mellitus
title_fullStr Hepatobiliary dysfunction in Type-2 diabetes mellitus
title_full_unstemmed Hepatobiliary dysfunction in Type-2 diabetes mellitus
title_short Hepatobiliary dysfunction in Type-2 diabetes mellitus
title_sort hepatobiliary dysfunction in type-2 diabetes mellitus
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787956/
https://www.ncbi.nlm.nih.gov/pubmed/29417009
http://dx.doi.org/10.4103/2249-4863.222018
work_keys_str_mv AT manoriapiyush hepatobiliarydysfunctionintype2diabetesmellitus
AT inamdarsameer hepatobiliarydysfunctionintype2diabetesmellitus
AT kumarravindra hepatobiliarydysfunctionintype2diabetesmellitus